Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mechanisms of dyslipidemia of chronic renal failure.

Literature DB >> 16441821

Mechanisms of dyslipidemia of chronic renal failure.

Abstract

Chronic renal failure is associated with profound dysregulation of lipid metabolism and marked abnormalities of plasma lipid profile. This review is intended to provide an overview of the molecular basis of lipid disorders in chronic renal failure and explore their potential impact on cardiovascular disease and energy metabolism.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2006 PMID： 16441821 DOI： 10.1111/j.1542-4758.2006.01168.x

Source DB: PubMed Journal: Hemodial Int ISSN： 1492-7535 Impact factor: 1.812

Keyword Cloud
Cited

37 in total

Review 1. PCSK9 in chronic kidney disease.

Authors: P Pavlakou; E Liberopoulos; E Dounousi; M Elisaf
Journal: Int Urol Nephrol Date: 2017-01-13 Impact factor: 2.370

Review 2. Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.

Authors: Nosratola D Vaziri
Journal: Clin Exp Nephrol Date: 2013-08-24 Impact factor: 2.801

3. Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients.

Authors: Tae Ik Chang; Elani Streja; Melissa Soohoo; Tae Woo Kim; Connie M Rhee; Csaba P Kovesdy; Moti L Kashyap; Nosratola D Vaziri; Kamyar Kalantar-Zadeh; Hamid Moradi
Journal: Clin J Am Soc Nephrol Date: 2017-02-13 Impact factor: 8.237

Mechanisms of dyslipidemia of chronic renal failure.

Review 1. PCSK9 in chronic kidney disease.

Review 2. Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.

3. Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients.

Review 4. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.

Review 5. Role of lipotoxicity in endothelial dysfunction.

6. Lipid abnormalities, lipoprotein (a) and apoprotein pattern in non-dialyzed patients with chronic kidney disease.

Review 7. Causes of dysregulation of lipid metabolism in chronic renal failure.

Review 8. Role of HDL dysfunction in end-stage renal disease: a double-edged sword.

9. Interruption of antiretroviral therapy is associated with increased plasma cystatin C.

Review 10. High-density lipoprotein in uremic patients: metabolism, impairment, and therapy.